- Home
- PCB vs ABEO Comparison
PCB vs ABEO Comparison
Compare PCB & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCB | ABEO |
|---|---|---|
| Founded | 2003 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.0M | 281.0M |
| IPO Year | N/A | 1980 |
Fundamental Metrics
Financial Performance| Metric | PCB | ABEO |
|---|---|---|
| Price | $22.45 | $5.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $24.50 | $18.20 |
| AVG Volume (30 Days) | 20.6K | ★ 1.2M |
| Earning Date | 01-27-2026 | 03-19-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | ★ 43.50 | N/A |
| EPS | ★ 2.41 | 1.29 |
| Revenue | ★ $107,743,000.00 | $400,000.00 |
| Revenue This Year | $21.55 | N/A |
| Revenue Next Year | $8.65 | $1,589.77 |
| P/E Ratio | $9.12 | ★ $4.03 |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $16.00 | $3.93 |
| 52 Week High | $24.04 | $7.54 |
Technical Indicators
Market Signals| Indicator | PCB | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 47.85 |
| Support Level | $21.75 | $5.00 |
| Resistance Level | $23.21 | $5.41 |
| Average True Range (ATR) | 0.57 | 0.24 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 34.74 | 20.76 |
Price Performance
Historical ComparisonAbout PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.